Kazazian Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History
Kazazian Asset Management, LLC
- $123 Billion
- Q1 2025
A detailed history of Kazazian Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 11,840 shares of BBIO stock, worth $551,507. This represents 0.33% of its overall portfolio holdings.
Number of Shares
11,840
Previous 13,520
12.43%
Holding current value
$551,507
Previous $371 Million
10.33%
% of portfolio
0.33%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
387Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.03 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$897 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$694 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$580 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$334 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.91B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...